Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Cell analysis deals with the study of cells, which are isolated from tissues in multicellular organisms and unicellular organisms. Cellular analysis plays a vital role in gene identification, protein identification epigenomics, and other life science-related areas. Single cell analysis is an emerging field which measures transcripts cell by cell. SCA is an ideal tool for gaining a deep understanding of biological heterogeneity and contributing to therapeutic decisions. It has been applied to breast cancer, lung cancer, brain cancer, colon cancer, bladder cancer, acute myeloid leukemia, and melanoma etc. SCA is widely applied to clinical research and medical application. Single-cell sequencing is an ideal phenomenon for the investigation of genomes of microbes that cannot be cultured. The North America single cell analysis market is anticipated to witness significant growth due to increase in corporate and government funding for cell-based research and rise in prevalence of chronic diseases in this region.
The demand of the single cell analysis is driven by include increasing healthcare expenditure, prevalence of infectious diseases, increasing investments in cancer research, and rising biotechnology and biopharmaceutical industries in recent years. In clinical diagnostics, the single cell analysis is expected to standardize and automate workflows with valuable information for real-time monitoring of cancer and eventually new therapeutic strategies for the benefit of patients.
The cancer had a major impact on the North American region. As per the estimates of the National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to be diagnosed in the United States, and 609,640 deaths were expected from the disease. Circulating tumor cells are gaining increasing clinical attention since they are likely to enable the monitoring of cancer progression and adjustment of treatment. In such cases, the single cell sequencing analysis has found its application in search of better diagnostic and prognostic biomarkers, thereby boosting the growth of the single cell analysis market
The impact of the COVID-19 pandemic is very wide and occupies almost every aspect of life across the world with the wave of direct health impacts cutting across each nation at different paces. The impact on the economies of all countries has been dramatic and has yet to become fully apparent. Laboratory research and research based on experimental models were significantly impacted by university directed ramping down of nonessential research. However, the outbreak of COVID-19 is expected to have a minimal or negligible impact on the single cell analysis market. The rise in the incidences of COVID has led to an increase in the need for an efficient drug or vaccine for COVID, which could help in reducing the severity of the cases. Cell-based research is an essential step during the manufacturing of vaccines, which can help in the growth of the market.
The report analyses the single cell analysis market based on product, call type, application, end user and countries
Single cell analysis products includes instruments and consumables. Various consumables required for single cell analysis consists of beads, microplates, reagents, assay kits etc. instruments incorporates flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems and microarrays. The consumables segment accounts for the major market share as consumables are used in large volume in the market. Thus, the disposable nature makes them a vital repeat purchase as opposed to devices, resulting in them being a top selling product in this market. Moreover, the high usage of the product across multiple applications, such as probing, identification, sorting, and immuno-phenotyping can be attributed to the growth of the segment.
The major applications of the market includes research and medical application. The research application segment held the maximum revenue share owing to an exponential rise in stem cell-based research and the huge success of regenerative medicine are expected to fuel market growth. Moreover, increasing awareness regarding commercially available cancer diagnostics. In the research segment, cancer and immunology is of growing interest among the scientific communities.
The major end users of the market includes academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and cell banks & IVF centers. Hospitals and diagnostic laboratories segment is expected to emerge as the lucrative source of revenue in the forthcoming years, due to the ongoing efforts to bridge the gap for implementation of OMICs technology from research laboratories to clinical settings
The North America single cell analysis market is studied across the various countries of this regions including USA, Canada and Mexico. United States accounted for the lion’s share of the market. he large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on cell therapies, growing awareness regarding advanced treatment methods, increasing geriatric population, and the strong presence of industry players in the region.
Some of the major players operating in the global single cell analysis market include Becton, Dickinson and Company, Danaher Corporation, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc., General Electric Company, 10x Genomics, Promega Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Nanostring Technologies, Inc., Sartorius AG, Luminex Corporation and Fluxion Biosciences among others.
The report analyses the single cell analysis market based on product, call type, application, end user and countries. Single cell analysis products includes instruments and consumables. Various consumables required for single cell analysis consists of beads, microplates, reagents, assay kits etc. instruments incorporates flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems and microarrays. The major applications of the market includes research and medical application. The major end users of the market includes academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and cell banks & IVF centers.
Some of the major players opening in this region include Becton, Dickinson and Company, Danaher Corporation, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc., General Electric Company, 10x Genomics, Promega Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Nanostring Technologies, Inc., Sartorius AG, Luminex Corporation and Fluxion Biosciences among others. Regionally, the Single Cell Analysis market is studied across the countries of key regions such as, USA, Canada and Mexico.
Why to Buy This Report
